Middle East Tensions and Central Bank Hawkishness Rattle Global Markets; Zealand Pharma Plunges 32%

Geopolitical Developments - The Middle East conflict has escalated, with missile alerts in Dubai and explosions over Tel Aviv, leading to increased oil prices and disruptions in regional aviation [2][3][9] - Analysts warn that a prolonged blockade of the Strait of Hormuz could push oil prices towards $100 per barrel [3] Central Bank Policies - The European Central Bank (ECB) is under pressure, with money markets pricing in an 80% chance of a rate hike by December 2026 due to inflation risks [4][9] - In Asia, the Bank of Japan (BoJ) is speculated to have a 50% chance of a benchmark rate hike next month, while the People's Bank of China (PBOC) plans to support the economy through interest rate and RRR cuts [5] Corporate Movements - Zealand Pharma (ZEAL) experienced a 32% drop in market value following disappointing clinical data for its obesity drug, impacting the broader European biotech sector [6][9] - Ford Motor Company (F) is recalling 889,950 vehicles in the U.S. due to safety defects as reported by the NHTSA [7][9] - Atos (ATO) and ITV (ITV) saw gains of 6.4% and 5.7% respectively, while Lufthansa (LHA) rose by 3.0% on news of flight resumptions [6]